Pharmaceutical Industry News Roundup: March 2020

by Staff Writer

Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from March:

Coronavirus (COVID-19) Update: FDA continues to facilitate development of treatmentsU.S. Food & Drug Administration (FDA)

This FDA update describes the agency’s “multifaceted” response to the COVID-19 pandemic. The FDA response includes deploying medical countermeasures to treat the disease, surveil supply chains, and helping mitigate such impacts.

Read the full update

Canton research firm offers $1M grant for coronavirus vaccine researchFOX 2 Detroit

MMS is offering a $1 million award for the development of a vaccine for COVID-19. The award is meant to help researchers overcome financial roadblocks to develop a treatment for the virus.

FOX 2 Detroit has the full story

WHO, UN Foundation and partners launch first-of-its-kind COVID-19 Solidarity Response FundWorld Health Organization (WHO)

A new COVID-19 Solidarity Response Fund has been developed by the United Nations Foundations and the Swiss Philanthropy Fund, along with WHO.  The fund will raise money from various donors to support WHO and its partners to help countries respond to the pandemic.

Learn more via WHO

COVID-19 vaccine tracker—Regulatory Focus

Regulatory Focus has put together a tracker for COVID-19 vaccine development. The tracker lists major vaccine candidates in development for COVID-19 prevention.

Jeff Craven has the story

Real-world data analysis and considerations for useJournal of Clinical Pathways

Winston Wong, PharmD and Editor-in-Chief of Journal of Clinical Pathways writes that real-world data (RWD) and real-world evidence (RWE) should only be considered for use after safety and efficacy of a drug is proven. He then uses tumor lysis syndrome (TLS) as a case study for using RWD and RWE.

View the editorial by Winston Wong, PharmD

Joint FDA, industry real-world evidence center issues research frameworksMedTech Dive

The National Evaluation System for Health Technology Coordinating Center (NESTcc) recently published two documents on best practices for collecting and using RWE for research on medical devices. The NESTcc said the documents will be updated in the future based on test cases and RWE projects.

Read Amritpal Sandhu-Longoria’s piece here

< Back to MMS Blog